Xenon Pharmaceuticals Inc. (XENE) SEC Filings — 2024
13 SEC filings for Xenon Pharmaceuticals Inc. (XENE) in 2024.
Filings
- Xenon Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Xenon Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Xenon Pharma Q2 2024 Update: Financials & Equity Offerings — 10-Q · Aug 8, 2024
- Xenon Pharmaceuticals Files 8-K for Shareholder Votes & Exhibits — 8-K · Jun 5, 2024
- Xenon Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Xenon Pharmaceuticals Inc. Files Definitive Proxy Statement — DEF 14A · Apr 26, 2024
- Xenon Pharmaceuticals Reports Director Changes and Compensation Updates — 8-K · Apr 19, 2024
- Xenon Pharmaceuticals Files 8-K Report — 8-K · Mar 8, 2024
- Xenon Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
- Xenon Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Xenon Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- FMR LLC & Abigail Johnson Hold 7.556% Stake in Xenon Pharma — SC 13G/A · Feb 9, 2024
- Wellington Management Takes 5.0% Stake in Xenon Pharma — SC 13G · Feb 8, 2024